laitimes

Mindray Medical: Won the control of Huitai Medical at a premium of 25%.

author:Fanghua 360

In the rivers and lakes of medical devices, the strong is king, and Mindray Medical stands among them, shocking the Quartet. However, the rivers and lakes are changing rapidly, and there are many subdivisions, and the strong also need to find a new way to continue to be brilliant. Mindray Medical decided to enter the cardiovascular field in order to dominate the industry.

In the field of cardiovascular disease, the global market is as vast as the sea, and the Chinese market is particularly vast. Nowadays, the aging of the population is intensifying, and the growth rate of the cardiovascular market is beyond the ordinary. Huitai Medical, the hero of this territory, has lived in the rivers and lakes for a long time, and has a full range of R&D and production capacity of products, and is a leader in the country.

Mindray Medical: Won the control of Huitai Medical at a premium of 25%.

The innovation of Huitai Medical has attracted worldwide attention. Its electrophysiology electrode catheter, controllable radiofrequency ablation catheter, and floating temporary pacing electrode catheter are the first of their kind in China, and have won the honor of national key new products issued by the Ministry of Science and Technology. In the field of vascular intervention, Huitai Medical has also made achievements, filling a number of domestic clinical gaps. The strength of such innovation has made Huitai Medical's performance soar and its reputation is shocking.

Mindray Medical wants to acquire a controlling stake in Huitai Medical in order to quickly enter the cardiovascular track. For this reason, he did not hesitate to throw money at it. It is reported that the acquisition cost is about 450 yuan per share, which is 25% higher than the latest closing price of Huitai Medical. Explaining the purpose of the acquisition, Mindray said: "This acquisition is not for immediate benefits, but for the long-term development of the company. Through mergers and acquisitions of excellent domestic companies, we intend to help Mindray quickly enter the cardiovascular track. ”

Mindray Medical: Won the control of Huitai Medical at a premium of 25%.

In the rivers and lakes of medical devices, the strong is king, and Mindray Medical stands among them, shocking the Quartet. However, the rivers and lakes are changing rapidly, and there are many subdivisions, and the strong also need to find a new way to continue to be brilliant. Mindray Medical decided to enter the cardiovascular field in order to dominate the industry.

Mindray Medical: Won the control of Huitai Medical at a premium of 25%.

Mindray's heart is a thousand miles away. The acquisition of Huitai Medical will surely inject strong impetus into its cardiovascular field. In the future, what kind of changes will the cooperation between Mindray and Huitai bring to the cardiovascular field?

#我来唠家常#

Read on